Abstract
As an effort to identify immune suppressive molecules in gastric cancer cells, a signal sequence trap was employed. Among the genes identified, 9-27 gene was highly expressed in gastric tumor tissues and in cancer cell lines. It was induced by IFN-gamma treatment, but not by TNF-alpha or TGF-beta1 treatment. The overexpression of 9-27 in the gastric cancer cells rendered tumor cells more resistant to natural killer cells. In addition, the 9-27-overexpressed cells showed an increased migration and an invasive capacity when compared with the control cells. Taken together, these data indicate that 9-27 plays a role in malignant progression by suppressing natural killer cells and by increasing the invasive potential of gastric cancer cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / immunology
-
Adenocarcinoma / therapy
-
Antigens, Differentiation
-
Antineoplastic Agents / pharmacology*
-
Cell Movement / drug effects*
-
Gene Expression Profiling
-
Humans
-
Interferon-gamma / pharmacology*
-
Killer Cells, Natural / drug effects*
-
Membrane Proteins / genetics
-
Membrane Proteins / metabolism*
-
Neoplasm Invasiveness / pathology*
-
Stomach Neoplasms / immunology*
-
Stomach Neoplasms / therapy
-
Transforming Growth Factor beta / pharmacology
-
Transforming Growth Factor beta1
-
Tumor Cells, Cultured / drug effects
-
Tumor Necrosis Factor-alpha / pharmacology
Substances
-
Antigens, Differentiation
-
Antineoplastic Agents
-
Membrane Proteins
-
TGFB1 protein, human
-
Transforming Growth Factor beta
-
Transforming Growth Factor beta1
-
Tumor Necrosis Factor-alpha
-
leu-13 antigen
-
Interferon-gamma